NL-OMON37376已完成不适用
An open-label, single center study to determine the absorption, distribution, metabolism, and excretion (ADME) of a single oral dose of [14C]LDE225 (74 kBq) to healthy male subjects - LDE225 ADME study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- ovartis
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male volunteers
- •18-55 years, inclusive
- •BMI: 18.0 * 32.9 kg/m2, inclusive
- •non-smoking
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS.
- •In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study.
- •In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
Effect of Moisturizer in Female Subjects with Mild to Moderate EczemaCTRI/2021/02/031309Wipro Manufacturing Services Sdn Bhd24
已完成
不适用
Safety and Efficacy study of Moisturizer.CTRI/2020/05/025465Wipro Manufacturing Services Sdn Bhd20
已完成
不适用
Safety and Efficacy of Body Lotion and Body Wash in Adult Female Subjects with Mild To Moderate Eczema.CTRI/2021/03/032149Wipro Manufacturing Services Sdn Bhd22
已完成
1 期
To establish safety and performance of RespirAId R20 -mechanical ventilation device in PatientsCTRI/2020/10/028638Remidio Innovative Solutions Pvt Ltd5
已完成
不适用
A single-center, open-label study to investigate the absorption, distribution, metabolism and excretion (ADME) of LEE011 after a single oral dose of 600 mg [14C]LEE011 (0.37 MBq) in healthy male subjectsgevorderde kankeradvance cancerNL-OMON40904ovartis6